Aesthetics Journal: Allergan Completes Kythera Acquisition

Global pharmaceutical company Allergan has announced that it has completed the acquisition of Kythera Biopharmaceuticals, Inc in a transaction valued at approximately $2.1 billion. The acquisition adds the treatment Kybella (deoxycholic acid), which became the first FDA approved non-surgical injection for submental fullness in April of this year, to Allergan’s portfolio. Brent Saunders, CEO and … Continue reading Aesthetics Journal: Allergan Completes Kythera Acquisition